Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pulsed introduction of low-dose RANKL as a therapy for osteogenesis imperfecta

Pulsed introduction of low-dose RANKL as a therapy for osteogenesis imperfecta

US Patent 10111928 · Granted Oct 30, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pulsed introduction of low-dose RANKL as a therapy for diet-induced atherosclero2020
Pulsed introduction of low-dose RANKL as a therapy for atherosclerosis2019
Suppression of bone loss by introducing FoxP3+ CD8 T-cells (TcREG)2017
Suppression of bone loss by introducing FoxP3+ CD8 T-cells (TcREG)2015
Sequence covariance networks, methods and uses therefor2014
Human methionine aminopeptidase type 32005
Methionine aminopeptidase type 32003
Cytokine family member EF-72001